Triazoloquinazolines as a new class of potent α-glucosidase inhibitors: in vitro evaluation and docking study.

MLA

Hatem A Abuelizz, et al. “Triazoloquinazolines as a New Class of Potent α-Glucosidase Inhibitors: In Vitro Evaluation and Docking Study.” PLoS ONE, vol. 14, no. 8, Jan. 2019, p. e0220379. EBSCOhost, https://doi.org/10.1371/journal.pone.0220379.

APA

Hatem A Abuelizz, El Hassane Anouar, Rohaya Ahmad, Nor Izzati Iwana Nor Azman, Mohamed Marzouk, & Rashad Al-Salahi. (2019). Triazoloquinazolines as a new class of potent α-glucosidase inhibitors: in vitro evaluation and docking study. PLoS ONE, 14(8), e0220379. https://doi.org/10.1371/journal.pone.0220379

Chicago

Hatem A Abuelizz, El Hassane Anouar, Rohaya Ahmad, Nor Izzati Iwana Nor Azman, Mohamed Marzouk, and Rashad Al-Salahi. 2019. “Triazoloquinazolines as a New Class of Potent α-Glucosidase Inhibitors: In Vitro Evaluation and Docking Study.” PLoS ONE 14 (8): e0220379. doi:10.1371/journal.pone.0220379.